NEW YORK (GenomeWeb) – Agendia said today that its MammaPrint 70-gene signature test that measures risk of recurrence in breast cancer has received the highest medical evidence level 1A label in German Association of Gynecological Oncology (AGO) guidelines for breast cancer care in Germany.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.